Home
Logos Global Management reported a 3.2% stake in Avalo Therapeutics AVTX · 1,675,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.2%
- Last report
- 5.6% · filed 26/04/01
- Shares held
- 1,675,000 sh
- Class
- Common Stock
- Holder
- Logos Global Management
- Event date
- 26/03/31
- Filed
- 26/05/15
3.2% stake · below 5%
- Stake
- 3.2%
- Last report
- 5.6%
- Since last report
- −2.4pp
Avalo Therapeutics trades, last 26 weeks
What else happened in Avalo Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Logos Global Management's other 5% stake reports
- Logos Global Management
5% stakeLongeveron
5% stakeLongeveron
LGVN
6.3% stake
192,308 sh
6.3% stake
Filed 09/10
- Logos Global Management
5% stakeAchieve Life Sciences
5% stakeAchieve Life Sciences
ACHV
9.99% stake
10,538,440 sh
9.99% stake
Filed 08/17
- Logos Global Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
9.9% stake
276,704 sh
9.9% stake
Filed 08/04
- Logos Global Management
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
3% stake
800,000 sh
3% stake
Filed 05/15
- Logos Global Management
5% stakeiBio
5% stakeiBio
IBIO
0% stake
0 sh
0% stake
Filed 05/15
